Instituto Medico Platense
La Plata, Buenos Aires B1900AVG
0 studies enrolling now · 9 studies all time
What they study most
COVID, Covid-19, Covid19, Infectious Pneumonia, Influenza, Influenza and Other Novel Respiratory Viruses, Melanoma, Metastases, Novel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV), Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV), RSV Infection, SARS-CoV2 Infection
Studies at this site
- Outpatient Treatment With Anti-Coronavirus Immunoglobulin — Paused
- Reparixin add-on Therapy to Standard Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia — Stopped early
- A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications. — Completed
- Respiratory Virus Hospitalization Study (FLU 003 Plus) — Completed
- Immune Modulators for Treating COVID-19 — Completed
- CPI-006 Plus Standard of Care Versus Placebo Plus Standard of Care in Mild to Moderately Symptomatic Hospitalized Covid-19 Patients — Stopped early
- Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir) Versus Oseltamivir for the Treatment of Influenza in Adults at Risk for Complications — Completed
- Respiratory Virus Outpatient Study (FLU 002 Plus) — Completed
- MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma — Completed